Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 4
2007 3
2008 7
2009 18
2010 14
2011 25
2012 27
2013 26
2014 19
2015 13
2016 8
2017 4
2018 2
2019 2
2020 4
2021 2
2022 1
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation.
Honda A, Tahara N, Tahara A, Bekki M, Maeda-Ogata S, Sugiyama Y, Igata S, Nishino Y, Matsui T, Kurata S, Abe T, Yamagishi SI, Fukumoto Y. Honda A, et al. J Nucl Cardiol. 2023 Aug;30(4):1613-1626. doi: 10.1007/s12350-023-03200-y. Epub 2023 Feb 3. J Nucl Cardiol. 2023. PMID: 36737518 Clinical Trial.

Both anti-hypertensive drugs comparably lowered blood pressure and increased %FMD. TBR values were reduced by olmesartan (P < .001), while blood pressure variability was decreased by amlodipine (P = .004). Changes in %FMD from baseline (delta%FMD) were inversely associa

Both anti-hypertensive drugs comparably lowered blood pressure and increased %FMD. TBR values were reduced by olmesartan (P < .001

Olmesartan medoxomil/amlodipine.
Sanford M, Keam SJ. Sanford M, et al. Drugs. 2009;69(6):717-29. doi: 10.2165/00003495-200969060-00005. Drugs. 2009. PMID: 19405551 Review.
black triangle Olmesartan medoxomil/amlodipine is a fixed-dose combination of olmesartan medoxomil and amlodipine, both established antihypertensive agents. Dose titration with the individual constituent drugs is recommended before switching to the equivalent fixed- …
black triangle Olmesartan medoxomil/amlodipine is a fixed-dose combination of olmesartan medoxomil and amlodipine, both establ …
Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
Erdine S. Erdine S. Ther Adv Cardiovasc Dis. 2012 Feb;6(1):31-44. doi: 10.1177/1753944711432902. Epub 2012 Jan 5. Ther Adv Cardiovasc Dis. 2012. PMID: 22222315 Free article. Review.
Importantly, the efficacy and tolerability of olmesartan plus amlodipine is not affected by age, gender, hypertension severity, diabetes status, race or body mass index. Additional blood pressure lowering effects are observed with stepwise uptitration of olmesartan
Importantly, the efficacy and tolerability of olmesartan plus amlodipine is not affected by age, gender, hypertension severity, diabe …
Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension.
Ram CV. Ram CV. Expert Rev Cardiovasc Ther. 2011 Jan;9(1):9-19. doi: 10.1586/erc.10.163. Expert Rev Cardiovasc Ther. 2011. PMID: 21166525 Review.
Regimens combining three or more antihypertensive agents have been shown to increase the proportion of patients achieving BP goals. Recent data suggest that the combination of olmesartan medoxomil, amlodipine and hydrochlorothiazide is a rational treatment option offering …
Regimens combining three or more antihypertensive agents have been shown to increase the proportion of patients achieving BP goals. Recent d …
Olmesartan/amlodipine: a review of its use in the management of hypertension.
Kreutz R. Kreutz R. Vasc Health Risk Manag. 2011;7:183-92. doi: 10.2147/VHRM.S16852. Epub 2011 Mar 29. Vasc Health Risk Manag. 2011. PMID: 21490944 Free PMC article. Review.

Significantly greater reductions in seated diastolic BP were observed between baseline and after eight weeks of treatment with olmesartan/amlodipine, compared with equivalent doses of olmesartan or amolodipine monotherapy (P < 0.001), in the factorial Combination

Significantly greater reductions in seated diastolic BP were observed between baseline and after eight weeks of treatment with olmesartan
Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors.
Oh J, Kim W, Kim GH, Kim HL, Park SD, Min KW, Hyun D, Hong JH, Lim S, Shin J; RESOLVE-INT Investigators. Oh J, et al. Adv Ther. 2023 Nov;40(11):4817-4835. doi: 10.1007/s12325-023-02632-9. Epub 2023 Aug 31. Adv Ther. 2023. PMID: 37651078 Free PMC article.
METHODS: This prospective, multicenter observational study assessed the real-world safety and effectiveness of an SPC containing olmesartan, amlodipine, and hydrochlorothiazide (O/A/H) in South Korean patients with hypertension and cardiovascular risk factors. ...
METHODS: This prospective, multicenter observational study assessed the real-world safety and effectiveness of an SPC containing olmesart
Olmesartan medoxomil/amlodipine/hydrochlorothiazide: fixed-dose combination in hypertension.
Deeks ED. Deeks ED. Drugs. 2011 Jan 22;71(2):209-20. doi: 10.2165/11206770-000000000-00000. Drugs. 2011. PMID: 21275446 Review.
The antihypertensive agents olmesartan medoxomil, amlodipine and hydrochlorothiazide (HCTZ) are now available as a fixed-dose combination tablet (olmesartan medoxomil/amlodipine/HCTZ). ...Data from a number of smaller clinical studies indicated that olmesartan
The antihypertensive agents olmesartan medoxomil, amlodipine and hydrochlorothiazide (HCTZ) are now available as a fixed-dose combina …
Efficacy and safety of olmesartan medoxomil-amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single-arm, multi-center, real-world study.
Cui Z, Qiu Z, Cheng W, Hu W, Ma G, Cai X, Jin Y, Zhao Y, He L, Li Y, Bu P, Chen X, Wang R, Chen L, Dong P, Feng L, Han X, Hong M, Hou Y, Liao M, Wang M, Wang X, Xie J, Xu Y, Wang Z, Huang K, Li Y, Li D, Ji X, Huang J, Wang J, Fang D, Wang J, Tang L, Liu Y, Fu G, Du J, Wang L, Liu M, Ge J. Cui Z, et al. J Clin Hypertens (Greenwich). 2024 Jan;26(1):5-16. doi: 10.1111/jch.14700. Epub 2023 Sep 4. J Clin Hypertens (Greenwich). 2024. PMID: 37667532 Free PMC article.
There lacks real-world study with a large sample size assessing olmesartan medoxomil-amlodipine besylate (OM-AML) tablet. Therefore, this study aimed to evaluate the efficacy and safety of OM-AML tablet in patients with essential hypertension. ...
There lacks real-world study with a large sample size assessing olmesartan medoxomil-amlodipine besylate (OM-AML) tablet. Therefore, …
Efficacy of amlodipine and olmesartan medoxomil in hypertensive patients with diabetes and obesity.
Punzi H, Shojaee A, Waverczak WF, Maa JF. Punzi H, et al. J Clin Hypertens (Greenwich). 2011 Jun;13(6):422-30. doi: 10.1111/j.1751-7176.2010.00422.x. Epub 2011 Feb 1. J Clin Hypertens (Greenwich). 2011. PMID: 21649842 Free PMC article.
Patients received amlodipine 5 mg/d and were uptitrated (if seated [Se] BP was 120/80 mm Hg) at 3-week intervals to amlodipine/olmesartan medoxomil 5/20 mg/d, 5/40 mg/d, and 10/40 mg/d. In patients with diabetes and obesity, baseline 24-hour ambulatory BP ( standard deviat …
Patients received amlodipine 5 mg/d and were uptitrated (if seated [Se] BP was 120/80 mm Hg) at 3-week intervals to amlodipine/olmesartan
The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}.
Xu M, Zhang X, Ye R, Liu X, Sun L, Jia S, Zhang Z, Li X, Wang Z, Liao H, Shi R, Liu K, Wang S, Meng Q, Chen X. Xu M, et al. Trials. 2023 Nov 28;24(1):770. doi: 10.1186/s13063-023-07726-x. Trials. 2023. PMID: 38017457 Free PMC article.
METHODS AND ANALYSIS: This study is being performed as a randomized, multicenter, open-label, parallel-group, clinical trial in which 720 participants are to undergo 24-h ambulatory blood pressure measurement (ABPM) and office blood pressure measurement (OBPM) at baseline before …
METHODS AND ANALYSIS: This study is being performed as a randomized, multicenter, open-label, parallel-group, clinical trial in which 720 pa …
167 results